e-learning
resources
London 2016
Tuesday, 06.09.2016
The best clinical approach to lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary tuberculosis and lung cancer: A complex interaction
Insaf Mejri (Tunis, Tunisia), Insaf Mejri, Besma Ourari, Hela Cherif, Jihen B. Amar, Heifa Zaibi, Saloua Azzabi, Med Ali Baccar, Hichem Aouina
Source:
International Congress 2016 – The best clinical approach to lung diseases
Session:
The best clinical approach to lung diseases
Session type:
Thematic Poster
Number:
3721
Disease area:
Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Insaf Mejri (Tunis, Tunisia), Insaf Mejri, Besma Ourari, Hela Cherif, Jihen B. Amar, Heifa Zaibi, Saloua Azzabi, Med Ali Baccar, Hichem Aouina. Pulmonary tuberculosis and lung cancer: A complex interaction. Eur Respir J 2016; 48: Suppl. 60, 3721
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Lung cancer and lung tuberculosis: Our results of treatment in the combined lung disease
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
The association of lung cancer with active pulmonary tuberculosis.
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014
Confirmed pulmonary tuberculosis leading to late diagnosis of lung cancer - Study case
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
Miliary disease of the lung: What is your diagnosis?
Source: Annual Congress 2013 –Morphologic imaging
Year: 2013
Treatment of pulmonary carcinoid: Are there new options?
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014
Active TB in cancer patients: A missed screening opportunity?
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Lung function in the elderly patients with a diagnosis of lung cancer - A challenge for the surgical treatment?
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015
Prevalence of COPD and emphysema at the time of diagnosis of primary lung cancer
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Lung cancer in women: Is it different?
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Improving NLST criteria for lung cancer screening
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Solitary pulmonary nodule: How accurate are our predictions?
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Perioperative outcomes of RATS pulmonary lobectomy for lung cancer and tuberculosis in a learning curve setting
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015
Does every necrotizing granulomatous inflammation at NSCLC resection materials require treatment?
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016
Network-based approach identifies SP1 as a common node in emphysema and lung cancer
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Delay in diagnosis and management of lung cancer in developing countries
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016
Concomitant latent tuberculosis in patients with lung cancer
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
Latent tuberculosis infection and the risk of cancer: A nationwide population-based study
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015
Lung diseases infection and risk of lung cancer
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Survival in lung cancer: Associated factors in Tunisian patients
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
Methilation status in EBUS-NA samples of lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept